Oncogenic function of DACT1 in colon cancer through the regulation of β-catenin

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Yuan, Guohong ^a   Wang, Chongkai ^a   Ma, Chaolai ^a   Chen, Ning ^a   Tian, Qinghe ^a   Zhang, Tonglin ^a   Fu, Wei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; SERINE; DACT1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER TISSUE; CELL CYCLE REGULATION; CELL MEMBRANE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; DACT1 GENE; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CELL STRAIN HCT116; CELL STRAIN HT29; COLON TUMOR; DRUG ANTAGONISM; G1 PHASE CELL CYCLE CHECKPOINT; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; TUMOR CELL LINE; XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; COLONIC NEOPLASMS; CYTOPLASM; G1 PHASE CELL CYCLE CHECKPOINTS; GLYCOGEN SYNTHASE KINASE 3; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84863338705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034004     Document Type: Article

References (48)

1. Giles RH, van Es JH, Clevers H, (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24.
2. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
3. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, et al. (2007) Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317: 803-806.
4. Liu C, Li Y, Semenov M, Han C, Baeg GH, et al. (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847.
5. Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, et al. (2008) Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 452: 650-653.
6. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790.
7. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, et al. (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250.
8. Tetsu O, McCormick F, (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
9. Ashton-Rickardt PG, Dunlop MG, Nakamura Y, Morris RG, Purdie CA, et al. (1989) High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene 4: 1169-1174.
10. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600.
11. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237.
12. Hamada F, (2009) [Wnt signaling and cancer]. Kaibogaku Zasshi 84: 111-112.
13. Polakis P, (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17: 45-51.
14. Cheon SS, Cheah AY, Turley S, Nadesan P, Poon R, et al. (2002) beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci U S A 99: 6973-6978.
15. Moon RT, Kohn AD, De Ferrari GV, Kaykas A, (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701.
16. Cheyette BN, Waxman JS, Miller JR, Takemaru K, Sheldahl LC, et al. (2002) Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation. Dev Cell 2: 449-461.
17. Katoh M, (2003) Identification and characterization of human DAPPER1 and DAPPER2 genes in silico. Int J Oncol 22: 907-913.
18. Yau TO, Chan CY, Chan KL, Lee MF, Wong CM, et al. (2005) HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Oncogene 24: 1607-1614.
19. Yang ZQ, Zhao Y, Liu Y, Zhang JY, Zhang S, et al. (2010) Downregulation of HDPR1 is associated with poor prognosis and affects expression levels of p120-catenin and beta-catenin in nonsmall cell lung cancer. Mol Carcinog 49: 508-519.
20. Wong HC, Bourdelas A, Krauss A, Lee HJ, Shao Y, et al. (2003) Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. Mol Cell 12: 1251-1260.
21. Chen Y, Shi L, Zhang L, Li R, Liang J, et al. (2008) The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283: 17969-17978.
22. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
23. Hendriksen J, Jansen M, Brown CM, van der Velde H, van Ham M, et al. (2008) Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway. J Cell Sci 121: 1793-1802.
24. Aberle H, Butz S, Stappert J, Weissig H, Kemler R, et al. (1994) Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci 107 (Pt 12): 3655-3663.
25. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, et al. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599.
26. Marikawa Y, Elinson RP, (1998) beta-TrCP is a negative regulator of Wnt/beta-catenin signaling pathway and dorsal axis formation in Xenopus embryos. Mech Dev 77: 75-80.
27. Salomon D, Sacco PA, Roy SG, Simcha I, Johnson KR, et al. (1997) Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J Cell Biol 139: 1325-1335.
28. Yanagawa S, Matsuda Y, Lee JS, Matsubayashi H, Sese S, et al. (2002) Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila. EMBO J 21: 1733-1742.
29. Etienne-Manneville S, Hall A, (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421: 753-756.
30. Johnson M, Sharma M, Jamieson C, Henderson JM, Mok MT, et al. (2009) Regulation of beta-catenin trafficking to the membrane in living cells. Cell Signal 21: 339-348.
31. Staal FJ, Noort MM, Strous GJ, Clevers HC, (2002) Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 3: 63-68.
32. Stambolic V, Woodgett JR, (1994) Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303 (Pt 3): 701-704.
33. Sutherland C, Leighton IA, Cohen P, (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296 (Pt 1): 15-19.
34. Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, et al. (2006) Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res 66: 5278-5286.
35. Wang CK, (2011) The role of DACT1 in colon cancer. Peking University, Master's graduate thesis.
36. Gloy J, Hikasa H, Sokol SY, (2002) Frodo interacts with Dishevelled to transduce Wnt signals. Nat Cell Biol 4: 351-357.
37. Jiang X, Tan J, Li J, Kivimae S, Yang X, et al. (2008) DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 13: 529-541.
38. Hulsken J, Birchmeier W, Behrens J, (1994) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127: 2061-2069.
39. Cadigan KM, Nusse R, (1997) Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305.
40. Cox RT, Peifer M, (1998) Wingless signaling: the inconvenient complexities of life. Curr Biol 8: R140-144.
41. Dale TC, (1998) Signal transduction by the Wnt family of ligands. Biochem J 329 (Pt 2): 209-223.
42. Zhang L, Gao X, Wen J, Ning Y, Chen YG, (2006) Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J Biol Chem 281: 8607-8612.
43. Brembeck FH, Rosario M, Birchmeier W, (2006) Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16: 51-59.
44. Eleftheriou A, Yoshida M, Henderson BR, (2001) Nuclear export of human beta-catenin can occur independent of CRM1 and the adenomatous polyposis coli tumor suppressor. J Biol Chem 276: 25883-25888.
45. Henderson BR, Fagotto F, (2002) The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep 3: 834-839.
46. Wiechens N, Fagotto F, (2001) CRM1- and Ran-independent nuclear export of beta-catenin. Curr Biol 11: 18-27.
47. Ciani L, Krylova O, Smalley MJ, Dale TC, Salinas PC, (2004) A divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubules. J Cell Biol 164: 243-253.
48. Dominguez I, Green JB, (2000) Dorsal downregulation of GSK3beta by a non-Wnt-like mechanism is an early molecular consequence of cortical rotation in early Xenopus embryos. Development 127: 861-868.